Cervical cancer
Conditions
Interventions
Part I: observation group:NA
Part II:Control group:Provide routine care after gynecological oncology radiotherapy to the selected high-risk population, including health guidance and targeted follow-up.
Part II:Intervention group:Provide evidence-based preventive interventions to the selected high-risk population, combined with routine care after gynecological oncology radiotherapy.
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Part I: Development and Validation of a Clinical Early Warning Model for Radiation-Induced Enteritis Following Cervical Cancer Surgery Inclusion Criteria: 1.Patients who underwent radiotherapy after cervical cancer surgery; 2.Conscious with normal cognitive and verbal expression abilities; 3.Voluntarily cooperated and provided signed informed consent. Part II: Evidence-Based Practice for the Prevention of Acute Radiation-Induced Enteritis After Radiotherapy Following Cervical Cancer Surgery Inclusion Criteria 1.High risk patients identified through screening; 2.Patients and their families who are conscious, have normal thinking, and are proficient in using smartphones; 3.Patients and their families who have normal reading and expression abilities; 4.Patients and their families who voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: Part I: Development and Validation of a Clinical Early Warning Model for Radiation-Induced Enteritis Following Cervical Cancer Surgery Exclusion Criteria: 1.Patients who underwent curative radiotherapy; 2. Patients with a history of acute or subacute intestinal obstruction, Crohn's disease, ulcerative colitis, intestinal tuberculosis, intestinal lipodystrophy syndrome (Whipple's syndrome), or other pre-existing intestinal symptoms unrelated to radiotherapy. Part II: Evidence-Based Practice for the Prevention of Acute Radiation-Induced Enteritis After Radiotherapy Following Cervical Cancer Surgery Exclusion Criteria: 1.Patients and/or their family members unwilling to cooperate with scheduled hospital check-ups; 2.Patients who withdrew from the study midway or whose condition deteriorated during the study period, making them unable to continue participation. 3.Solitary individuals.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of acute enteritis; | — |
Countries
China
Contacts
Public ContactJiajia Zhang
Fudan University Shanghai Cancer Center
Outcome results
None listed